1. Home
  2. NVAX vs ATEN Comparison

NVAX vs ATEN Comparison

Compare NVAX & ATEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • ATEN
  • Stock Information
  • Founded
  • NVAX 1987
  • ATEN 2004
  • Country
  • NVAX United States
  • ATEN United States
  • Employees
  • NVAX N/A
  • ATEN N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ATEN EDP Services
  • Sector
  • NVAX Health Care
  • ATEN Technology
  • Exchange
  • NVAX Nasdaq
  • ATEN Nasdaq
  • Market Cap
  • NVAX 1.3B
  • ATEN 1.1B
  • IPO Year
  • NVAX 1995
  • ATEN 2014
  • Fundamental
  • Price
  • NVAX $6.66
  • ATEN $16.90
  • Analyst Decision
  • NVAX Buy
  • ATEN Buy
  • Analyst Count
  • NVAX 6
  • ATEN 2
  • Target Price
  • NVAX $17.83
  • ATEN $21.00
  • AVG Volume (30 Days)
  • NVAX 8.5M
  • ATEN 975.5K
  • Earning Date
  • NVAX 05-08-2025
  • ATEN 05-01-2025
  • Dividend Yield
  • NVAX N/A
  • ATEN 1.42%
  • EPS Growth
  • NVAX N/A
  • ATEN 9.85
  • EPS
  • NVAX 2.97
  • ATEN 0.67
  • Revenue
  • NVAX $1,254,962,000.00
  • ATEN $267,158,000.00
  • Revenue This Year
  • NVAX N/A
  • ATEN $9.23
  • Revenue Next Year
  • NVAX N/A
  • ATEN $7.49
  • P/E Ratio
  • NVAX $2.24
  • ATEN $25.29
  • Revenue Growth
  • NVAX 25.92
  • ATEN 4.90
  • 52 Week Low
  • NVAX $4.43
  • ATEN $12.27
  • 52 Week High
  • NVAX $23.86
  • ATEN $21.90
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.25
  • ATEN 54.66
  • Support Level
  • NVAX $5.82
  • ATEN $15.92
  • Resistance Level
  • NVAX $6.61
  • ATEN $17.51
  • Average True Range (ATR)
  • NVAX 0.53
  • ATEN 0.53
  • MACD
  • NVAX 0.02
  • ATEN 0.19
  • Stochastic Oscillator
  • NVAX 42.21
  • ATEN 74.52

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ATEN A10 Networks Inc.

A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.

Share on Social Networks: